KP
Karo Pharma AB Stock: price and insider trades · Sweden
ISIN SE0007464888SE·
No insider purchase over the last 90 days. The latest, by Carl Lindgren, was filed 28 Sept 2018.
Karo Pharma AB: what insiders have been doing
Karo Pharma AB is a listed company. Its directors and officers file their transactions with Finansinspektionen. Karo Pharma AB has had no insider filing for more than a year; the last one goes back to 24 January 2019.
Looking back to 2016, when coverage begins, insiders filed 51 purchases and 11 sales.
This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Insider Decl.
107
Thresholds
n/a
Buy Volume
€9M
51 ops. · all time
Sell Volume
€19M
11 ops. · all time
Last declaration on 24 January 2019
Declarations107 total
- 321,505 shares@ SEK 38.0083.8% of flowAktieISIN SE0007464888FI:csv-b4671e4895a2156fca20
- 33,015 shares@ SEK 38.0055.4% of flowAktieISIN SE0007464888FI:csv-d4dd8f3c38962c7e9e69
- 49,999 shares@ SEK 38.0074.6% of flowAktieISIN SE0007464888FI:csv-47546e1b1577dd1a1dee
- 3,300,000 shares@ SEK 38.0059.0% of flowAktieISIN SE0007464888FI:csv-530cb800eae58435c2ad
- 568,218 shares@ SEK 38.0077.6% of flowAktieISIN SE0007464888FI:csv-5959315cf61850b5c111
- 140,000 sharesAktieISIN SE0007464888FI:csv-6967532026fdac00445f
- 7,491 shares@ SEK 31.300.0% of flowAktieISIN SE0007464888FI:csv-2bfaab2b3d438d2cdb58Canonical exit: 27 Dec 2018 (T+90)
- 983,329 shares@ SEK 33.0014.9% of flowISIN SE0007464888FI:csv-6e916e06b250cfb44c76
- 2,509 shares@ SEK 24.000.0% of flowFI:csv-ef8a9f9a2774f5122075
- 90,791 shares@ SEK 24.000.0% of flowFI:csv-60d5837c9a13b0bb196b
- 22,632 shares@ SEK 24.000.0% of flowFI:csv-9281dfac19a533b60bd7
- 204,200 shares@ SEK 24.000.0% of flowFI:csv-d475e04d951d444f05fb
- 1,575 shares@ SEK 24.000.0% of flowISIN SE0007464888FI:csv-8d62560befaca17abe79
- 4,065 shares@ SEK 24.000.0% of flowISIN SE0007464888FI:csv-f94302f6ce69486f437c
- 13,500 shares@ SEK 24.002.2% of flowISIN SE0007464888FI:csv-313399520b60eb347a4a
- 1,745,992 shares@ SEK 24.000.1% of flowISIN SE0011204817FI:csv-6b5d80c9de41deb046ec
- 435,242 shares@ SEK 24.000.0% of flowISIN SE0011204817FI:csv-3efdfcf373315d9142c9
- 30,296 shares@ SEK 24.000.0% of flowISIN SE0007464888FI:csv-46b855a0095b48e57ceb
- 78,190 shares@ SEK 24.000.0% of flowISIN SE0007464888FI:csv-52fb3a5425416074e7eb
- 1,427,776 shares@ SEK 24.0016.0% of flowISIN SE0011204817FI:csv-65b35472cee24007cc5f
- 50,000 shares@ SEK 24.000.0% of flowISIN SE0010663039FI:csv-53c13b46750a6e165ef2Canonical exit: 28 Aug 2018 (T+90)
- 16,666 shares@ SEK 24.0015.5% of flowISIN SE0007464888FI:csv-237047b4431b10af1ed7
- 11,005 shares@ SEK 24.0011.5% of flowFI:csv-5e621f4d789830ed28fa
- 20,000 shares@ SEK 0.47880.0% of flowISIN SE0011204809FI:csv-4fb12d43ff6b2f249b28Canonical exit: 21 Aug 2018 (T+90)
- 85,000 shares@ SEK 0.6970.0% of flowISIN SE0011204809FI:csv-551cc26fbb7620bf2ac6Canonical exit: 16 Aug 2018 (T+90)
25 of 107 declarations
About Karo Pharma AB
Karo Pharma AB is a Swedish company focused on the development and commercialization of pharmaceutical and health products. It is listed on the Stockholm Stock Exchange.